Breast Cancer FemaleInfo Center
Losing Balance After Breast Cancer
Survivors of breast cancer may find it hard to stand strong as a result of the therapies they endured while fighting the cancer, according to new research.
Double Up on Vitamin D
Adults need around 4,000 to 8,000 IU daily of vitamin D to maintain levels of healthful vitamin D metabolites in the range needed to reduce the risk of several diseases by about half.
Practice Makes Perfect
Radiologists who read more mammograms tend to be better at determining which suspicious breast lesions are cancer, according to a new report from the Institute of Medicine.
Discovery Holds Hope for Pancreatic and Breast Cancer
Recent research has uncovered a protein implicated in both pancreatic and breast cancer tumors.
Researchers Discover New Breast Cancer Culprit
When scientists identify concentrations of regulatory T cells (immune-system cells) in breast cancer tumors, it usually signifies an unfavorable prognosis. Now researchers have uncovered why.
Resveratrol and Rapamycin: A Power Couple
Resveratrol, a compound found in red wine, may have a tumor-suppressing effect on breast cancer cells when combined with rapamycin, an immunosuppressant drug.
Fooled by Folic Acid?
According to a new study working with rat animal models, female offspring of rats who took folic acid supplements before conception, during pregnancy and while breast-feeding have twice the rate of breast cancer.
Breast Cancer Surgery May Become Less Invasive
A new study finds that removing underarm lymph nodes in women with early breast cancer (and who also undergo a lumpectomy) may not be necessary, thus saving them considerable pain and complications.
Aggressive Form of Breast Cancer Linked to Gene Mutation
A new study from Tufts University School of Medicine finds why individuals who inherit a particular family of mutations have a higher risk of developing a very aggressive form of breast cancer.
Illegal Drugs Aren't the Only Kind That Kill
Avastin®, a cancer drug, has been shown to increase patient death from adverse events when used in conjunction with chemotherapy or biological therapy, according to new analysis of previous studies.